1. Covid-19: UK launches antivirals taskforce to deliver home treatments by autumn
2. Covid-19: Molnupiravir reduces risk of hospital admission or death by 50% in patients at risk, MSD reports
3. A study of PF-07321332/ritonavir in non-hospitalized low-risk adult participants with covid-19. ClinicalTrials.gov. Sep 2021. https://clinicaltrials.gov/ct2/show/NCT05011513.
4. A study of PF-07321332/ritonavir in nonhospitalized high risk adult participants with covid-19. ClinicalTrials.gov. Oct 2021. https://clinicaltrials.gov/ct2/show/NCT04960202.
5. A post-exposure prophylaxis study of PF-07321332/ritonavir in adult household contacts of an individual with symptomatic covid-19. ClinicalTrials.gov. Oct 2021. https://clinicaltrials.gov/ct2/show/NCT05047601.